{
    "nctId": "NCT04890028",
    "briefTitle": "Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases",
    "officialTitle": "Detection and Metabolic Characterization in DOPA PET/CT of no Treated Brain Metastases of Lung Cancer, Breast Cancer and Melanoma",
    "overallStatus": "RECRUITING",
    "conditions": "Brain Metastases, MRI",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "Assess the sensitivity of 18F DOPA PET-CT for the detection of no treated brain metastases (breast cancer, lung cancer, melanoma), newly diagnosed by MRI and measuring at least 5 mm in diameter.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Primitive cancer (brest cancer, lung cancer, melanoma) proven histologically\n* Presence of brain metastasis visualized on MRI, of which at least one measures 5 mm\n* Age \\> 18 years\n* Patient has valid health insurance\n* Written informed consent obtained from the patient prior to performing any protocol-related procedures, including screening evaluations\n\nExclusion Criteria:\n\n* History of irradiation cerebral\n* History of brain surgery for brain metastasis or glial tumor\n* Systemic therapy (chemotherapy, targeted therapy, immunotherapy) modified in the 6 weeks preceding the realization of DOPA PET/CT,\n* New anti-tumor treatment started between the discovery of brain metastases and the performance of DOPA PET/CT\n* Other concomitant cancer, or history of cancer in the 5 years preceding the performance of DOPA PET/CT\n* Pregnant or lactating females\n* Persons deprived of their liberty, under a measure of safeguard of justice, under guardianship or placed under the authority of a guardian.\n\nDisorder precluding understanding of trial information or informed consent.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}